STING1 and neoplasm: Tumor-derived DNA captured by cGAS in DCs as well as tumor cells themselves in tumor microenvironment (TME) is the primary driving force to activate STING signaling to induce the production of type I IFN and the tumor-specific CD8+ T cell priming (Fig. 4).